Top Cited Papers
Open Access
Abstract
Background and Aims: Catheter ablation is performed in patients with recurrent ventricular tachycardia (VT) but remains complex and limited to experienced centres. Ventricular tachycardia ablation guided by pre-procedural imaging was shown promising in non-randomized trials. InEurHeart aims to evaluate computed tomography (CT)-guided VT ablation vs conventional ablation in a multicentre randomized controlled trial. Methods: In 14 European centres, 113 patients with prior myocardial infarction and clinically significant VT were randomly assigned to CT-guided (n = 57) or conventional (n = 56) VT ablation. The primary objective was to demonstrate reduced procedural duration when using CT guidance. Secondary endpoints included efficacy (incidence and burden of ventricular arrhythmia), safety, as well as composite endpoints. Results: The primary endpoint showed a significant decrease in procedure time favouring CT-guided ablation: 149 ± 51 to 120 ± 50 min, −19% [95% confidence interval (CI) −32; −7]; P = .0027 in intention to treat, and 149 ± 51 to 107 ± 38 min, −28% (95% CI −40; −16); P < .0001 per protocol. Major adverse events occurred in two (3.5%) in the conventional group vs one (1.8%) in the CT-guided group [−1.8% (95% CI −7.9; 4.3)]. Ventricular tachycardia–free survival at 1 year was achieved in 37 (67.3%) patients for conventional vs 43 (76.8%) for CT-guided VT ablation [9.5% (95% CI −10.4; 29.4), P = NS]. Ventricular tachycardia burden was decreased by 90% in the CT-guided group. Conclusions: In patients with ischaemic cardiomyopathy, CT-guided VT ablation reduces the procedure duration while maintaining a favourable efficacy and safety profile when compared with VT ablation without image integration.
Funding Information
  • EIT Health (220639)
  • French Government
  • Agence Nationale de la Recherche (ANR-10-IAHU-04)
  • Agence Nationale de la Recherche (ANR-24-DIME-0005)

This publication has 42 references indexed in Scilit: